vs
Cenntro Inc.（CENN）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Cenntro Inc.的1.8倍（$9.1M vs $5.0M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -1022.8%，领先962.5%），Cenntro Inc.同比增速更快（972.9% vs -49.9%），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -17.7%）
Cenntro Inc.是一家全球化商用电动车技术企业，主打轻型、中型商用电动车及智能出行解决方案，服务物流、城市配送、公共服务等领域，业务覆盖北美、欧洲、亚洲多地，专注提供高性价比的可持续末端运输产品。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
CENN vs PLX — 直观对比
营收规模更大
PLX
是对方的1.8倍
$5.0M
营收增速更快
CENN
高出1022.8%
-49.9%
净利率更高
PLX
高出962.5%
-1022.8%
两年增速更快
PLX
近两年复合增速
-17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.0M | $9.1M |
| 净利润 | $-50.7M | $-5.5M |
| 毛利率 | -54.9% | 49.4% |
| 营业利润率 | -229.9% | -51.1% |
| 净利率 | -1022.8% | -60.3% |
| 营收同比 | 972.9% | -49.9% |
| 净利润同比 | -189.4% | -184.8% |
| 每股收益（稀释后） | $-86.61 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CENNPLX
| Q4 25 | $5.0M | $9.1M | ||
| Q3 25 | $4.6M | $17.9M | ||
| Q2 25 | $2.1M | $15.7M | ||
| Q1 25 | $6.4M | $10.1M | ||
| Q4 24 | $-568.2K | $18.2M | ||
| Q3 24 | $16.2M | $18.0M | ||
| Q2 24 | $8.3M | $13.5M | ||
| Q1 24 | $7.3M | — |
净利润CENNPLX
| Q4 25 | $-50.7M | $-5.5M | ||
| Q3 25 | $-6.7M | $2.4M | ||
| Q2 25 | $-5.7M | $164.0K | ||
| Q1 25 | $-9.9M | $-3.6M | ||
| Q4 24 | $-17.5M | $6.5M | ||
| Q3 24 | $-9.0M | $3.2M | ||
| Q2 24 | $-9.2M | $-2.2M | ||
| Q1 24 | $-9.2M | — |
毛利率CENNPLX
| Q4 25 | -54.9% | 49.4% | ||
| Q3 25 | 2.3% | 53.4% | ||
| Q2 25 | 15.0% | 62.5% | ||
| Q1 25 | -0.3% | 19.1% | ||
| Q4 24 | 262.5% | 78.7% | ||
| Q3 24 | 38.8% | 53.4% | ||
| Q2 24 | 14.7% | 29.8% | ||
| Q1 24 | 21.6% | — |
营业利润率CENNPLX
| Q4 25 | -229.9% | -51.1% | ||
| Q3 25 | -150.4% | 11.9% | ||
| Q2 25 | -288.1% | 7.5% | ||
| Q1 25 | -126.4% | -41.0% | ||
| Q4 24 | 1644.3% | 39.6% | ||
| Q3 24 | -40.4% | 22.2% | ||
| Q2 24 | -106.0% | -18.0% | ||
| Q1 24 | -97.3% | — |
净利率CENNPLX
| Q4 25 | -1022.8% | -60.3% | ||
| Q3 25 | -146.7% | 13.2% | ||
| Q2 25 | -263.8% | 1.0% | ||
| Q1 25 | -154.4% | -35.8% | ||
| Q4 24 | 3084.9% | 35.6% | ||
| Q3 24 | -55.3% | 18.0% | ||
| Q2 24 | -110.4% | -16.4% | ||
| Q1 24 | -125.5% | — |
每股收益（稀释后）CENNPLX
| Q4 25 | $-86.61 | $-0.06 | ||
| Q3 25 | $-0.14 | $0.03 | ||
| Q2 25 | $-0.19 | $0.00 | ||
| Q1 25 | $-0.27 | $-0.05 | ||
| Q4 24 | $-86.39 | $0.10 | ||
| Q3 24 | $-0.29 | $0.03 | ||
| Q2 24 | $-0.30 | $-0.03 | ||
| Q1 24 | $-0.30 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.3M | $48.2M |
| 总资产 | $74.4M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CENNPLX
| Q4 25 | $4.5M | $14.7M | ||
| Q3 25 | $4.4M | $13.6M | ||
| Q2 25 | $6.0M | $17.9M | ||
| Q1 25 | $8.5M | $19.5M | ||
| Q4 24 | $12.6M | $19.8M | ||
| Q3 24 | $22.4M | $27.4M | ||
| Q2 24 | $20.2M | $23.4M | ||
| Q1 24 | $24.3M | — |
股东权益CENNPLX
| Q4 25 | $40.3M | $48.2M | ||
| Q3 25 | $76.0M | $52.9M | ||
| Q2 25 | $79.6M | $49.9M | ||
| Q1 25 | $73.3M | $45.2M | ||
| Q4 24 | $77.8M | $43.2M | ||
| Q3 24 | $96.7M | $32.4M | ||
| Q2 24 | $103.8M | $28.6M | ||
| Q1 24 | $112.5M | — |
总资产CENNPLX
| Q4 25 | $74.4M | $82.3M | ||
| Q3 25 | $112.7M | $82.3M | ||
| Q2 25 | $124.4M | $78.5M | ||
| Q1 25 | $129.3M | $73.9M | ||
| Q4 24 | $132.6M | $73.4M | ||
| Q3 24 | $159.8M | $61.6M | ||
| Q2 24 | $167.8M | $91.5M | ||
| Q1 24 | $173.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.8M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流CENNPLX
| Q4 25 | $-1.8M | $2.0M | ||
| Q3 25 | $-1.4M | $-3.7M | ||
| Q2 25 | $-4.4M | $-5.2M | ||
| Q1 25 | $-5.0M | $-5.1M | ||
| Q4 24 | $-8.5M | $4.0M | ||
| Q3 24 | $-201.6K | $4.1M | ||
| Q2 24 | $-3.8M | $-3.6M | ||
| Q1 24 | $-8.9M | — |
自由现金流CENNPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | $-1.5M | $-4.2M | ||
| Q2 25 | $-4.5M | $-5.7M | ||
| Q1 25 | $-5.5M | $-5.4M | ||
| Q4 24 | $-8.6M | $3.6M | ||
| Q3 24 | $-258.9K | $4.0M | ||
| Q2 24 | $-4.2M | $-3.8M | ||
| Q1 24 | $-9.2M | — |
自由现金流率CENNPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | -33.2% | -23.7% | ||
| Q2 25 | -211.2% | -36.2% | ||
| Q1 25 | -85.4% | -53.0% | ||
| Q4 24 | 1509.3% | 19.6% | ||
| Q3 24 | -1.6% | 22.4% | ||
| Q2 24 | -50.3% | -28.1% | ||
| Q1 24 | -125.7% | — |
资本支出强度CENNPLX
| Q4 25 | — | 4.4% | ||
| Q3 25 | 2.1% | 2.8% | ||
| Q2 25 | 5.6% | 2.8% | ||
| Q1 25 | 8.1% | 3.0% | ||
| Q4 24 | -22.1% | 2.3% | ||
| Q3 24 | 0.4% | 0.5% | ||
| Q2 24 | 4.0% | 1.3% | ||
| Q1 24 | 4.5% | — |
现金转化率CENNPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CENN
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
